372 related articles for article (PubMed ID: 15618155)
1. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
[TBL] [Abstract][Full Text] [Related]
2. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
Mucci J; Risso MG; Leguizamón MS; Frasch AC; Campetella O
Cell Microbiol; 2006 Jul; 8(7):1086-95. PubMed ID: 16819962
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
Gao W; Pereira MA
Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
[TBL] [Abstract][Full Text] [Related]
5. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
Mucci J; Hidalgo A; Mocetti E; Argibay PF; Leguizamon MS; Campetella O
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3896-901. PubMed ID: 11891302
[TBL] [Abstract][Full Text] [Related]
6. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo.
Leguizamón MS; Mocetti E; García Rivello H; Argibay P; Campetella O
J Infect Dis; 1999 Oct; 180(4):1398-402. PubMed ID: 10479182
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
[TBL] [Abstract][Full Text] [Related]
8. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
Dc-Rubin SS; Schenkman S
Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
[TBL] [Abstract][Full Text] [Related]
9. Oral exposure to Phytomonas serpens attenuates thrombocytopenia and leukopenia during acute infection with Trypanosoma cruzi.
da Silva RV; Malvezi AD; Augusto Lda S; Kian D; Tatakihara VL; Yamauchi LM; Yamada-Ogatta SF; Rizzo LV; Schenkman S; Pinge-Filho P
PLoS One; 2013; 8(7):e68299. PubMed ID: 23844182
[TBL] [Abstract][Full Text] [Related]
10. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.
Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO
Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786
[TBL] [Abstract][Full Text] [Related]
11. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
[TBL] [Abstract][Full Text] [Related]
12. The trans-sialidase from Trypanosoma cruzi efficiently transfers alpha-(2-->3)-linked N-glycolylneuraminic acid to terminal beta-galactosyl units.
Agustí R; Giorgi ME; de Lederkremer RM
Carbohydr Res; 2007 Nov; 342(16):2465-9. PubMed ID: 17765882
[TBL] [Abstract][Full Text] [Related]
13. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism.
Todeschini AR; Dias WB; Girard MF; Wieruszeski JM; Mendonça-Previato L; Previato JO
J Biol Chem; 2004 Feb; 279(7):5323-8. PubMed ID: 14634017
[TBL] [Abstract][Full Text] [Related]
14. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
15. Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.
Muiá RP; Yu H; Prescher JA; Hellman U; Chen X; Bertozzi CR; Campetella O
Glycobiology; 2010 Jul; 20(7):833-42. PubMed ID: 20354005
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ
Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381
[TBL] [Abstract][Full Text] [Related]
17. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling.
Todeschini AR; Nunes MP; Pires RS; Lopes MF; Previato JO; Mendonça-Previato L; DosReis GA
J Immunol; 2002 May; 168(10):5192-8. PubMed ID: 11994475
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase inhibits human lymphocyte proliferation by nonapoptotic mechanisms: implications in pathogenesis and transplant immunology.
Vercelli CA; Hidalgo AM; Hyon SH; Argibay PF
Transplant Proc; 2005 Dec; 37(10):4594-7. PubMed ID: 16387178
[TBL] [Abstract][Full Text] [Related]
19. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ
Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
[TBL] [Abstract][Full Text] [Related]
20. trans-Sialidase from Trypanosoma cruzi binds host T-lymphocytes in a lectin manner.
Todeschini AR; Girard MF; Wieruszeski JM; Nunes MP; DosReis GA; Mendonca-Previato L; Previato JO
J Biol Chem; 2002 Nov; 277(48):45962-8. PubMed ID: 12237289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
